Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07572591 · ClinicalTrials.gov registry record · NA
Ultrasound for Peripheral Nerve Modulation
A NA study, sponsored by Stanford University.
- Not yet
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT07572591: Clinical Trial NA study, sponsored by Stanford University.
NCT07572591 is a NA study that has not yet begun recruiting, run by Stanford University. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07572591, a NA study, has not yet begun recruiting, sponsored by Stanford University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This study evaluates an ultrasound device designed to reduce pain by targeting peripheral nerves without surgery or medication. The device is placed on the skin over the area of pain and delivers controlled ultrasound stimulation. Adults with nerve-related pain will participate in a single study visit that includes stimulation sessions and pain assessments. The goal of this study is to determine whether non-invasive ultrasound can safely and effectively reduce pain and to assess whether this approach is practical for future clinical use.
Interventions
- DEVICE Ultrasound
- DEVICE Sham (No Treatment)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07572591
The ClinicalTrials.gov registry entry for NCT07572591 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Ultrasound is the first listed.
NCT07572591 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07572591 about?
NCT07572591 is a clinical study titled "Ultrasound for Peripheral Nerve Modulation". This study evaluates an ultrasound device designed to reduce pain by targeting peripheral nerves without surgery or medication. The device is placed on the skin over the area of pain and delivers controlled ultrasound stimulation. Adults with nerve-related pain will participate in a single study vi...
What is the current status of trial NCT07572591?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 90 participants. The study started on 2026-06. Estimated completion is 2027-06.
What interventions are being tested in trial NCT07572591?
The interventions under investigation include: Ultrasound (DEVICE), Sham (No Treatment) (DEVICE).
Who is sponsoring clinical trial NCT07572591?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.